Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents

Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong-Hyun, Suh, Soon Yong, Kim, Seong Hwan, Lim, Sang-Yup, Roh, Seung-Young, Kim, Ji-Bak, Song, Woo Hyuk, Ahn, Jeong Cheon
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877790/
https://www.ncbi.nlm.nih.gov/pubmed/20514336
http://dx.doi.org/10.4070/kcj.2010.40.5.243
Descripción
Sumario:Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA).

Ejemplares similares